MERGE is hiring an EVP to grow its "flagship Pharma and MedTech portfolio" and a VP and Director for "one of our fastest-growing areas", and Supernus has just widened a 7-year relationship into a full Agency of Record. Yet the pharma case studies are the thinnest on the site: the Supernus page is 66 words and Dojolvi, YESCARTA and iRhythm run 109-150, none with a measured result, while Kroger gets 1,235 words and BVI shows market share rising from 4% to 10-15%. A pharma marketer comparing agencies sees MERGE's best proof in grocery, not in their own category.
First action
Ask Supernus which outcomes from the seven-year relationship can be published.
How to measure it
Pharma RFP invitations
- Now
- –
- Target
- +30%
- By
- 2 quarters
Steps
List outcomes
Approved metrics per client and programme.
Sr. Account Director 1 week
Client review
Each client's MLR or communications approval.
EVP, Account Management 3 weeks
Rewrite Supernus
Challenge, approach, outcomes, quote.
Chief Marketing Officer 1 week
Rewrite three more
YESCARTA, Dojolvi, iRhythm.
Chief Marketing Officer 2 weeks
Results boxes
Three numbers at the top.
Designer 1 week
Serve in HTML
No body text behind client-side components.
Web Engineering Lead 1 week
Use in pitches
Pharma credentials deck links.
EVP, Account Management ongoing
Why it works
Rebuild the four pharma case studies with the outcomes clients will approve through their medical, legal and regulatory review: HCP reach and engagement, site and portal use, field-enablement adoption, launch milestones. Lead with Supernus (seven years, two sales forces), add a results box and a short client quote, and serve the full text in the page HTML. Link them from the Pharma and MedTech page and every pharma pitch.
Life sciences buyers choose agencies on category proof, and specific, approved outcomes are what both people and AI assistants quote when shortlisting.
Ready to use
ChecklistPharma case study checklist
[ ] Therapy area and audience (HCP, patient, field) [ ] Challenge in one sentence [ ] What MERGE built [ ] Three approved outcome figures [ ] Client quote with title [ ] Approval reference on file [ ] Full text in served HTML [ ] Linked from Pharma and MedTech page
Risks and how to handle them
Clients decline to share figures
Use relative or indexed results, or anonymize by therapy area.
Regulatory review slows publishing
Submit all four together with the exact wording.
Evidence
- HiringPharma hiring: an EVP, Account Management (October 7, 2026) to "Lead MERGE's flagship Pharma and MedTech portfolio as a core business builder" and set its "multi-year vision and annual growth strategy"; a VP and a Director, Pharma Media (August 21) for "one of our fastest-growing areas of pharmaceutical work", "focusing heavily on HCP audiences and integrated HCP/DTC programs"; and a Sr. Account Director with life science and pharma experience.Source
- Your websiteAgency update, June 17, 2026: Supernus Pharmaceuticals named MERGE its comprehensive Agency of Record, expanding a 7-year partnership across its central nervous system portfolio; Supernus' VP of Marketing says the role "spans all our personal promotion efforts and supports two sales forces".Source
- Your websiteCase study page text as served (checked October 22, 2026): Supernus 66 words, Dojolvi 109, BVI Medical 113, YESCARTA 139 and iRhythm 150, against 1,235 for Kroger and 943 for James Hardie. The Supernus, Dojolvi, YESCARTA and iRhythm pages state no measured result; BVI lists "Growth from 4% market share to 10-15%". Each page's served HTML ends in a "Loading component..." placeholder.Source
- Your websitePharma and MedTech page: "Drive faster uptake and stronger market share with connected experiences that unite field, HCP, and patient engagement"; focus areas omnichannel, HCP and vet engagement, commercial enablement, brand and storytelling; recent work GE Healthcare, Dojolvi and iRhythm; a quote from Kite Pharma's VP, Global Marketing. The "Our clients" block arrives as "Loading component..." in the served HTML.Source